CorMedix Inc.
CRMD
$12.08
$0.585.04%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 240.11% | 242.71% | 191.26% | 71.50% | -25.53% |
| Total Depreciation and Amortization | 111.83% | 642.66% | 614.97% | 334.83% | 341.95% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 108.42% | 43.01% | 9.34% | 21.98% | 19.23% |
| Change in Net Operating Assets | 676.07% | 13.66% | -851.82% | -156,506.41% | -179.44% |
| Cash from Operations | 313.62% | 214.02% | 47.75% | -56.94% | -63.78% |
| Capital Expenditure | 31.32% | 83.36% | 96.65% | 3.92% | -443.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -420.27% | -102.05% | -132.93% | 1,198.01% | 364.92% |
| Cash from Investing | -422.43% | -102.18% | -150.89% | 1,177.08% | 362.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6,880.16% | -- | 2,324.18% | -67.19% | -78.44% |
| Repurchase of Common Stock | -77.42% | -949.43% | -- | -- | 29.69% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 7,778.31% | 6,374.87% | 2,312.83% | -67.19% | -80.25% |
| Foreign Exchange rate Adjustments | 900.00% | 125.00% | -150.00% | 119.05% | -150.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,485.34% | 402.89% | 155.44% | -79.93% | -19.74% |